In addition to MDMA, the organizations included the U.S. Chamber of Commerce, the National Association of Manufacturers and the National Federation of Independent Business.
If the 2.3 percent tax is not repealed, the organizations’ letter to Congress warned that devicemakers might consider cutting manufacturing operations, research and development, and employment to recoup the lost earnings.
Read the Medical Device Manufacturers Association release on the medical device tax.
Related Articles on the Medical Device Tax:
Devicemakers Ask Congress to Ease Regulatory Burdens on Industry
AdvaMed Unveils Policy Recommendations Aimed at Protecting U.S. Medical Innovation
Medical Device Lobby Calls for 6 Changes in Federal Policy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
